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A B S T R A C T
This is the protocol for a review and there is no abstract. The objectives are as follows:
To assess the effects of information interventions which orient patients and their carers/family to a cancer care facility and the services
available in the facility.
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B A C K G R O U N D
Description of the condition
Approximately 24.6million people experienced cancer around the
world in 2002 (WHO 2005). According to theWorld Health Or-
ganisation (WHO), the number of new cancer cases is projected
to increase from 10.9 million per year in 2002, to 16 million
per year by 2020 (WHO 2005). Around one third of all cancer
patients experience prolonged psychological distress and anxiety
levels that may contribute to ongoing adjustment difficulties, and
interfere with treatment adherence (Sellick 2007; Sussman 1995).
Further, the psychological distress does not only affect cancer pa-
tients, but also their partners, families and carers (Nijboer 2000;
Welch 1996).
Description of the intervention
There is consensus that information needs exist across the con-
tinuum of cancer care for patients and family/carers (Rees 2000;
Rutten 2005; Rutten 2006). However, we know little about the
best timing for providing specific information. The initial visit of a
cancer patient to the oncology centre can be especially distressing
(Mohide 1996). Factors contributing to this anxiety and distress
may include recent cancer diagnosis, uncertainty about treatment,
needle phobias, concerns about treatment length, and unfamiliar-
ity with the environment and with care providers (Carelle 2002;
Wells 1995). It has been demonstrated that information provision
can reduce anxiety and mood disturbances in cancer patients (
Mills 1999).
While much attention has focused on preparing cancer patients
for threatening medical treatment such as chemotherapy and ra-
diotherapy (Dunn 2004; Schofield 2008), information in relation
to the actual facility and supportive services available can easily be
left out of structured information-giving interventions. Therefore,
the intervention under consideration is any program or strategy
that orients patients to a cancer care facility; that is, any interven-
tion aiming to familiarise patients and their carers by giving them
information about the cancer care facilities and services available
to them therein (e.g. opening hours, role of the healthcare team).
Cancer patients may be receiving treatment in various settings
other than a specialised cancer centre. For example, cancer pa-
tients can receive treatment in a general medical centre without a
specialised cancer department due to inconsistent resources avail-
able in various regions (Borras 2001). Information may be deliv-
ered using strategies such as audiovisual aids, written information,
telephone helplines and face-to-face teaching (McPherson 2001).
Moreover, there has also been an increasing awareness of different
needs among cancer patients with varying levels of health liter-
acy (ability to understand health materials) and diverse cultural
backgrounds (Huang 1999; Wilson 2000). Although different in-
formation needs exist, orientation interventions aim to provide
generic information that is needed by all cancer patients during
their early encounters with a cancer care facility.
How the intervention might work
Information provision may reduce distress by enhancing patients’
sense of control. An enhanced sense of control, in turn, relieves
anxiety and enhances management of illness (Chelf 2001). Specif-
ically, evidence has suggested that providing cancer and surgical
patients with information about the procedure they are about
to undergo can significantly reduce their emotional distress and
improve their psychological and physical recovery (Burish 1991;
Johnston 1993). Other benefits related to the provision of in-
formation specifically for cancer patients may include increased
patient involvement in decision-making and greater satisfaction
with treatment choices (Luker 1995); improved ability to cope
during the diagnosis, treatment, and post-treatment phases (
Harrison-Woermke 1993); and improved communication with
family members (Rutten 2006).
Why it is important to do this review
Information is important for cancer patients and their family/car-
ers throughout the continuum of cancer care. Although the ben-
efits of information have been emphasised, patients and family
members often report that their information needs are not suffi-
ciently met (Champman 2003; Rees 2000). Orientation programs
aim to address information needs at the start of a person’s dealings
with a cancer care facility. These programsmay consume consider-
able resources but the extent of any benefit is unknown. Indeed, we
acknowledge that it is possible that harm may be caused. Dubois
2008 indicated that un-useful information may be undesirable in
new cancer patients. We also acknowledge that this review is nar-
rowly focused as we are considering the intervention at a particular
time point (before the first cancer treatment). However, meeting
information needs at different stages is important in cancer care.
Relationship to other relevant reviews
Rodin and colleagues conducted a systematic review on the effects
of treatment for depression in cancer (Rodin 2007). The review
focused on depression as an outcome; orientation programs were
not the specific subject of the review. The authors found that an
orientation program reduced depressed, but they did not assess
any of the other outcomes of interest in the current review.
O B J E C T I V E S
To assess the effects of information interventions which orient
patients and their carers/family to a cancer care facility and the
services available in the facility.
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M E T H O D S
Criteria for considering studies for this review
Types of studies
Wewill include randomised controlled trials (RCTs), cluster RCTs
and quasi-RCTs.
Types of participants
Participants must be new oncology patients and carers who re-
ceive an orientation intervention, which includes information and
education about the facility or services where they are to receive
care. The interventions must be given to patients who are about to
receive treatment or care in a cancer centre or a cancer department
of a general medical facility. This review will only consider adults
(over 18 years old) due to the different nature of information needs
in paediatric patient populations. Participants may have any type
of cancer at any stage, and may be about to receive inpatient or
outpatient treatment.
Types of interventions
Any information intervention with the primary goal of orienting
patients and their carers to a cancer care facility or services. Con-
tent must include information about the care facility and services
available in the facility (such as information about the healthcare
team) as the core component of the intervention. The intervention
can be delivered by healthcare professionals, administrative staff,
volunteers or a combination. It can be delivered in any mode or a
combination of modes, including:
• individual face to face;
• group intervention (including family-based interventions);
• telephone;
• video or audio materials;
• computer based/ technology based (e.g. internet);
• written materials.
The intervention could be a single intervention with the primary
goal of orientation, or part of a complex intervention. If part of a
complex intervention, it must be possible to separately identify the
effects of the orientation intervention. The orientation interven-
tion could be compared to usual care or compare different modes
and intensities of the intervention. Intensities may be measured by
duration of the intervention or number of components involved
in the intervention.
Based on the nature of orientation, we will exclude interven-
tions which are delivered after the first cancer treatment has com-
menced. This is to avoid the inclusion of educational interven-
tions during the course of treatment. The intervention may be
presented in any setting, for instance in hospital or at home.
Types of outcome measures
We will seek data on outcomes in the following categories:
Primary outcomes
Consumer-oriented outcomes:
• Knowledge and understanding (e.g. knowledge acquisition;
retention of information; ability to recall information);
• Health status and wellbeing (e.g. physical or psychological
health, coping or quality of life, measured by any instrument
used by the trial investigator);
• Evaluation of care (e.g. satisfaction of patients and carers
measured by any instrument used by the trial investigator);
• Harms (any adverse effects caused in the patients)
Secondary outcomes
Consumer-oriented outcomes:
• Communication e.g. improved communication or
relationship with provider;
• Skills acquisition e.g. self-care skills;
• Behavioral outcomes e.g. adherence to visits/ adherence to
treatment.
Service delivery oriented outcomes:
• Service delivery level e.g. cost of orientation interventions,
service use;
• Health professional outcomes e.g. satisfaction.
We will extract outcome data irrespective of whether it was col-
lected with a validated tool. However, in appraising the studies we
will discuss the validity and reliability of the outcome measures
used.
Search methods for identification of studies
Electronic searches
The Cochrane Consumers and Communication Review Group
will search their Specialised Register.
We will search:
• MEDLINE Ovid SP (1966- present)
• Cochrane Central Register of Controlled Trials
(CENTRAL)
• EMBASE Ovid (1966- present)
• CINAHL EBSCO (1982- present)
3Information interventions for orienting patients and their carers to cancer care facilities (Protocol)
Copyright © 2010 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
• PsycINFO Ovid (1966- present)
• Current Contents ISI (1998- present)
• Web of Science ISI (1966- present)
The search strategies have been developed to comprise searches us-
ing keywords andmedical subject headings under existing database
organizational schemes. The strategy for MEDLINE (Ovid SP) is
presented at Appendix 1.
There will be no restriction on language. Foreign language ab-
stracts will be initially translated for the application of the inclu-
sion and exclusion criteria, and where necessary the methods, re-
sults and discussion sections will be translated for inclusion in the
review.
Searching other resources
Wewill search the reference lists of any relevant studies and reviews.
We will also scan contents pages of relevant journals for articles
about interventions which orient patients to cancer care facilities,
as well as abstracts from relevant conference proceedings. The
relevant journals will include Patient Education and Counseling,
Psycho-Oncology, Oncology Nursing Forum, and Cancer Nursing.
We will also contact experts in the field and authors of included
studies for advice about other potentially relevant studies.
We will search the ProQuest Dissertations and Theses database
for grey literature. We will search databases in TrialsCentral
(www.trialscentral.org), the WHO Clinical Trial Search Por-
tal (www.who.int/trialsearch) and Current Controlled Trials
(www.controlled-trials.com) to identify ongoing or recently com-
pleted studies. If applicable, we will present relevant ongoing stud-
ies in a table in the review.
Data collection and analysis
Selection of studies
Two review authors will pre-screen all search results (titles and ab-
stracts) for possible inclusion, and those selected by either or both
authors will be subject to full-text assessment. Two review authors
will independently assess the selected articles for inclusion. Any
discrepancies will be resolved by consensus, overseen by a third
author acting as arbiter, with approval by one review author and
the arbiter being sufficient to include the study. We will list those
studies excluded after full-text assessment in the table ’Character-
istics of Excluded Studies’, giving reasons for exclusion.
Data extraction and management
We will develop a data extraction form based on the Cochrane
Consumers and Communication Review Group’s template, and
pilot and amend it as necessary (see Appendix 2). At least two
authors will independently extract data using the data extraction
form. The forms will then be checked by a third author and any
errors or inconsistencies resolved. The first author will enter the
data into RevMan, with another author checking the accuracy of
data entry.
Assessment of risk of bias in included studies
We will assess and report on the risk of bias of included studies
in accordance with the guidelines in the Cochrane Handbook for
Systematic Reviews of Interventions (Higgins 2008), which rec-
ommends the explicit reporting of the following individual do-
mains:
• Sequence generation;
• Allocation concealment;
• Blinding of participants, personnel and outcome assessors
(assessed for each main outcome or class of outcome);
• Incomplete outcome data (assessed for each main outcome
or class of outcome);
• Selective outcome reporting;
• Other sources of bias.
This will lead to an overall assessment of the risk of bias of the
included studies (Ryan 2007). We will assess each of the risk of
bias items as ’yes’ (indicating a low risk of bias), ’no’ (a high risk
of bias), and ’unclear’ (risk of bias is unclear) based on the trial
reports and/or additional information provided by trial authors.
We will also examine and report the following:
• Validation and reliability of outcome measures;
• Whether the study obtained ethics committee approval and
ensured informed consent for participation;
• Use of standardised protocols for information delivery. We
will check for consistency of the delivery of interventions where
possible.
Two review authors will independently assess the risk of bias in
included studies, with any disagreements resolved by discussion
and consensus, and with a third author acting as arbiter. We will
present our assessment in risk of bias tables for each included study.
We will contact study authors for additional information about
the study methods as necessary. We will incorporate the results
of the risk of bias assessment into the review through narrative
description and commentary about each of the items mentioned.
Measures of treatment effect
For individual trials, for dichotomous (binary) outcomes we will
report odds ratios (ORs) and 95% confidence intervals (CIs). For
continuous outcomes, we will report the mean difference (MD)
or, if the scale of measurement differs across trials, the standardised
mean difference (SMD), each with its 95% CI.
We will analyse data using the Cochrane Collaboration’s Review
Manager (RevMan) 5 software.
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Unit of analysis issues
Unit of analysis errors will be checked if cross-over trials or cluster
randomised trials are included, althoughwe are unlikely to identify
relevant cross-over trials due to the orientation intervention oc-
curring before patients’ treatment. If required, and sufficient data
are available, we will recalculate the results using the appropriate
unit of analysis (Higgins 2008).
Dealing with missing data
We will contact study authors for missing data. Where complete
data are available, we will perform analysis on an intention-to-
treat (ITT) basis. If some outcome data remain missing despite
our attempts to obtain complete outcome data from authors, we
will perform an available-case analysis, based on the numbers of
patients for whom outcome data are known. If standard deviations
are missing, we will impute them from other studies, or where
possible, compute them from standard errors using the formula
SD=SE x
√
N, where these are available (Higgins 2008). We will
also report on levels of drop outs in the intervention and compar-
ison groups as an indicator of ’acceptability’ of the intervention,
and as a potential source of bias.
Assessment of heterogeneity
Heterogeneity will be tested using the Chi² statistic and any het-
erogeneity will be further quantified with the I² statistic (which
describes the percentage of the variability in effect estimates that is
due to heterogeneity rather than sampling error). A value greater
than 50%will be considered to represent substantial heterogeneity
(Higgins 2008).
Assessment of reporting biases
Reporting biaswill be assessed using guidelines inCochraneHand-
book for Systematic Reviews of Interventions (Higgins 2008). As
we do not expect to find a large number of studies it is unlikely that
publication or inclusion bias will be assessed. However, if enough
studies are available to do a meaningful assessment of publication
bias, wewill test for asymmetry using a funnel plot.We will discuss
the results of the funnel plot and possible explanations thereof,
which include publication bias but also other sources of bias such
as diverse methodological quality.
Data synthesis
For meta-analyses, for dichotomous outcomes, we will calculate
odds ratios (ORs) and for continuous outcomes, the mean differ-
ence (MD) or a summary estimate for standardised mean differ-
ence (SMD), each with its 95% CI.
We will group data within the tables according to study design
and type of intervention. If there are sufficient appropriate studies,
they will also be categorised based on whether the intervention
is aimed at patients or carers. Within these categories the results
will be further structured to reflect the comparisons detailed in
the Types of interventions sections (i.e. mode of delivery). We will
present separately the results of studies that compare the interven-
tion to no intervention, then those that compare the intervention
to other forms of orientation intervention (e.g. face to face ver-
sus audio/visual) and those that compare two or more types of
mode (e.g. written materials and video; written material and face
to face). We will use this synthesis to prepare a narrative review of
the results, and to examine included studies to assess clinical and
methodological heterogeneity. The narrative review will present
the results of the studies as relative and absolute percentage change
and direction of effect for each of the outcomes.
If the studies are sufficiently similar in terms of population, inclu-
sion criteria, interventions and/or outcomes (including the time(s)
at which these are assessed), we will consider pooling the data sta-
tistically using meta-analysis. We will perform a formal random-
effects model meta-analysis, which will report pooled MDs (con-
tinuous variables using the same scale) or SMDs (continuous vari-
ables using different scales) or ORs (dichotomous variables), with
95% CIs.
If cluster randomised trials are included, we will account for the
effects of clustering by adjusting each trial to its ’effective sample
size’ using intra-class coefficients where available, or external esti-
mates from similar studies. We will analyse separately the compar-
isons detailed in the previous paragraph. Separate meta-analyses
will be carried out for each of the primary outcomes and secondary
outcomes. The decision to carry out meta-analyses will be made
by consensus of RC and JW.
A summary of the results of the data synthesis and assessment
of the quality of the evidence will be included in a Summary of
Findings table.
Subgroup analysis and investigation of heterogeneity
No subgroup analysis is planned.
Sensitivity analysis
Wewill restrict the primary analysis to studieswhich are considered
as having a low risk of bias (ie. those receiving a ’Yes’ rating for the
criteria of sequence generation and allocation concealment).
Wewill also perform sensitivity analyseswhere appropriate in order
to explore the influence of the following factors on effect size:
• excluding unpublished studies;
• excluding any large studies to establish how they impact on the
results;
• excluding studies using the following filters: criteria used for
clinical diagnosis and eligibility for intervention,
language of publication, country;
• the length of the interval between registration to the service and
delivery of the intervention; and between delivery of the interven-
tion and measurement of the effect.
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We may also test the robustness of the results by repeating the
analysis using differentmeasures of effect size (risk difference, odds
ratio etc.) anddifferent statisticalmodels (fixed-effect and random-
effects models).
Consumer participation
The protocol has undergone standard Cochrane Consumers and
Communication Review Group editorial and external peer review,
which includes at least one consumer referee. This protocol also
includes a number of consumer-focused outcomes, guided by the
Cochrane Consumers and Communication Review Group taxon-
omy of outcomes.
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A P P E N D I C E S
Appendix 1. MEDLINE (Ovid) search strategy
1. exp neoplasms/
2. exp carcinoma/
3. (cancer* or oncolog* or neoplasm* or carcinom* or tumo?r* or malignan*).tw.
4. (leuk?emi* orAMLor lymphom* or hodgkin* orT-cell* or B-cell* or sarcom* orEwing* or osteosarcom* orwilms* or nephroblastom*
or neuroblastom* or rhabdomyosarcom* or teratom* or hepatom* or hepatoblastom* or medulloblastom* or PNET* or retinoblastom*
or meningiom* or gliom*).tw.
5. oncology service hospital/
6. exp medical oncology/
7. or/1-6
8. patient education as topic/
9. exp teaching materials/
10. (audio* or video* or cassette* or tape? or dvd* or compact dis* or cd or cds or multimedia or multi media).tw.
11. (internet or web or website* or online or on line or blog* or weblog* or podcast* or portal? or computer program* or computer
mediated or computer based or computer assisted).tw.
12. computer assisted instruction/
13. exp telephone/
14. (telephon* or phone or phones or text messag* or sms).tw.
15. (pamphlet* or booklet* or leaflet* or flyer* or brochure* or print* material*).tw.
16. ((education* or teaching or instruction* or counseling or advisory) adj (material* or program* or session*)).tw.
17. information services/
18. or/8-17
19. (service* or facilit* or center* or centre* or hospital* or clinic or department* or unit or therap* or treatment* or staff* or personnel
or team).tw.
20. 18 and 19
21. ((educat* or inform* or advis* or advice or counsel* or orient* or tour* or introduc* or familiar* or descri*) adj3 (service* or facilit*
or center* or centre* or hospital* or clinic or department* or unit or therap* or treatment* or staff* or personnel or team)).tw.
22. (orientation* or familiari*).tw.
23. or/20-22
24. 7 and 23
25. randomized controlled trial.pt.
26. controlled clinical trial.pt.
27. randomized.ab.
28. placebo.ab.
29. clinical trials as topic.sh.
30. randomly.ab.
31. trial.ti.
32. or/25-31
33. exp animals/ not humans.sh.
34. 32 not 33
35. 24 and 34
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Appendix 2. Data extraction form
The following main sets of data will be extracted from each included study:
• lead author; date;
• study participant inclusion criteria;
• participants (participant diagnoses/condition(s), stage of diagnosis and demographics: race/ethnicity, gender, religion/culture,
socioeconomic status, age);
• study design and timetable; randomisation; allocation concealment;
• interventions (content and format of interventions)
• intervention setting and delivery provider; delivery of any co-interventions, timing of intervention, the use of standardised
protocols, training of the intervention provider, components of intervention, theoretical basis of intervention if stated;
• numbers of participants in each trial arm;
• outcome measures; time(s) at which outcomes assessed;
• results;
• potential biases;
• analysis;
• additional comments.
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